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The events that lead to promoter accessibility within chromatin are not completely understood. The invariant
chain (Ii) promoter was used as a model to determine the contribution of different DNA-binding factors in
establishing occupancy of a complex promoter. Gamma interferon induction of the Ii promoter requires the
cooperation of multiple cis elements including distal S, X, and Y/CCAAT elements along with proximal GC and
Y/CCAAT elements. The heteromeric transcription factor NF-Y binds to both Y/CCAAT elements. Genomic
footprinting was used to analyze in vivo protein-DNA contacts for integrated Ii promoters bearing mutations
in each element. The results reveal a hierarchy of transcription factor loading with NF-Y binding to the distal
Y/CCAAT element being required for establishing protein-DNA interactions over the entire 250 bp analyzed.
Mutation of the X box disrupts binding primarily at the adjacent Y/CCAAT element along with a lesser effect
on GC box binding. Importantly, this finding is verified with a cell line which lacks a functional X-box-binding
factor, RFX, providing physiological validity for the strategy described here. Mutation of both the S element
and the GC box results in either no or little effect on transcription factor binding. However, mutation of the
proximal Y/CCAAT element disrupts binding to the adjacent GC box and partially reduces binding in the distal
S/X/Y domain. The crucial role for NF-Y in establishing promoter occupancy may be related to its histone fold
motif, the essential component for assembling nucleosome-like structures.
In order to recruit RNA polymerase II to the appropriate
site for initiation of transcription, multiple proteins of diverse
structures must first recognize their cognate DNA sequences in
cis-acting regulatory regions. In eukaryotic nuclei, these pre-
liminary events are complicated by the overall complexity of
the genome, which offers the potential for titration via non-
specific and specific interactions, and packaging of regulatory
sequences into chromatin, which can influence the accessibility
of binding sites. It has been proposed that the solution to these
complications involves the assembly of highly organized nu-
cleoprotein complexes which result from a combination of
protein-protein and protein-DNA interactions facilitated by
the arrangement of cis-acting elements within a promoter (21,
27, 54). Analyses of several enhancers have shown that some
DNA-binding proteins function principally as structural com-
ponents in organizing these short stretches of DNA into
functional nucleoprotein complexes. Virus induction of beta
interferon (IFN-b) transcription requires the assembly of an
enhanceosome (52). The IFN-b enhancer requires a precise
stereospecific alignment of regulatory sequences and the co-
operation of at least three different transcription factors and
the high-mobility group protein HMG I(Y) (18). HMG I(Y)
promotes the cooperative assembly of factors on the promoter
by binding to multiple sites in the enhancer and reversing
intrinsic DNA bends (23). In a separate system, assembly of
the T-cell receptor a enhancer requires the architectural pro-
tein lymphoid enhancer-binding factor 1 (LEF-1) (25). The
HMG domain of LEF-1 induces a 130-degree bend upon DNA
binding (24, 34), providing a mechanism for arranging the
apposition of distant regulatory elements. Spatial organization
of distant elements also can be influenced by the organization
of regulatory sequences into nucleosomes. Transcription of the
Xenopus vitellogenin gene in vitro requires a positioned nu-
cleosome that loops out the DNA between enhancer elements
and the core promoter which reside in linker regions (46).
Transcriptional regulation of genes involved in the major
histocompatibility complex (MHC) class II antigen presenta-
tion pathway offers an intriguing model for analyzing promoter
assembly (5, 26, 35, 53). Efficient presentation of exogenous
antigen to T helper cells requires the coordinate expression of
multiple genes including the a/b chains of DR, DQ, and DP,
the MHC class II-associated invariant chain (Ii), and the a/b
chains of DM. These genes are developmentally regulated with
constitutive expression in mature B cells and inducible regu-
lation in a variety of cell types. Three promoter elements
within each of these genes, S (W), X, and Y, are critical for
B-cell-specific and IFN-g-induced expression. The sequence
and spacing between these elements are highly conserved, and
functional studies have indicated that these elements act syn-
ergistically. Insertions and deletions that alter the spacing be-
tween X and Y have shown that helical alignment between
these two elements is required for function, and any spacing
change between S and X is not tolerated (56, 57). Biochemical
results suggest that physical interaction between the factors
binding at X and Y does occur and that binding at the X and
Y elements is cooperative (45, 60).
The Y element is a CCAAT box which is bound by the
heteromeric DNA-binding protein NF-Y (also known as CBF,
CP1, and YEBP) (13, 36, 63). Unlike the transcription factors
C/EBP and CTF/NF1, which also bind CCAAT-like sequences,
NF-Y exhibits a strict sequence requirement for this pen-
tanucleotide (16). Binding sites for this factor have been de-
scribed for several eukaryotic genes, and a statistical analysis
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of 502 unrelated eukaryotic promoters determined that Y/CC
AAT sequences frequently are observed in the promoter-prox-
imal sequences of these genes (9). NF-Y is composed of three
subunits, NF-YA, -B, and -C, each of which is required for
DNA binding (37, 49). Each of the subunits contains primary
sequence that has remained highly conserved throughout evo-
lution. In fact, subunits of the mammalian CCAAT-binding
factor can substitute for the homologous subunits of the yeast
CCAAT-binding factor, HAP2/3/5, in DNA-binding assays (14,
49). The conserved core sequences of NF-YC and NF-YB
contain a 70-amino-acid region that displays similarity to the
histone fold motif of the nucleosome subunits H2A and H2B,
respectively (4, 48). The unique structure and evolutionary
conservation of this transcription factor suggest that it plays a
fundamental role in transcription of eukaryotic genomes.
The X box is composed of two distinct DNA-binding ele-
ments, X1 and X2. The X1 element is bound by the heteromer-
ic transcription factor RFX (19). The absolute requirement for
RFX in regulation of MHC class II genes is exemplified by the
lack of X-box binding in cell lines derived from patients with
bare lymphocyte syndrome (44). One subunit of this factor,
RFX5, has recently been cloned by complementation of an
immortalized patient line (50), and a second subunit, RFXAP,
has been cloned by complementation of an in vitro-mutagen-
ized B-lymphoblastoid cell line (20). The X2 element is located
immediately 39 of X1 and is similar in sequence to TRE/CRE
sequences. A number of proteins have been described which
bind to this sequence, although the recently purified X2BP
cooperatively binds this site in the presence of purified RFX
(39). Transcriptional regulation of MHC class II genes also
requires the activity of the class II transactivator (CIITA) (51).
This factor does not seem to bind DNA, and its mode of action
remains unknown.
We previously examined the requirements of the S, X, and
Y/CCAAT elements in assembling a relatively simple minimal
DRA promoter in vivo (60). Cells harboring integrated mutant
DRA promoters were used to observe changes in promoter
occupancy which occur upon mutation of each element. Bind-
ing at the Y/CCAAT element was required for transcription
factor occupancy at the X1 and X2 sites. Occupancy at the X1
and X2 elements is codependent, while mutation at either of
these elements has a small effect on Y/CCAAT occupancy.
This analysis led to a description of the NF-Y/CCAAT box
interaction as a primary event in establishing occupancy of a
simple promoter.
Our previous result established the interrelationship be-
tween X and Y/CCAAT elements in the DRA gene, which
spans a mere 60 bp. However, many questions were left unan-
swered. For example, do all Y/CCAAT elements have this
effect on the binding of other elements? How far is this effect
observed? Is this effect dependent on adjacent sequences?
Since only a limited region was analyzed, these issues were not
addressed. These questions are now examined in the present
report, which is made possible only because the invariant chain
promoter is unique in that (i) two NF-Y (CBF) target sites are
present, one at the conventional site at 250 to 280 bp and one
further upstream at 2200 bp; (ii) sequences adjacent to these
two Y/CCAAT boxes are different, thus permitting us to ex-
amine the issue of how promoter context influences promoter
loading; and (iii) the entire promoter region spanning 250 bp
yields clear in vivo footprints, conferring a degree of resolution
at the nucleotide level that is not attainable with other tech-
niques. The results demonstrate a hierarchy of promoter load-
ing with both inter- and intradomain dependencies. Impor-
tantly, NF-Y binding is shown to be the most critical step in
promoter assembly.
MATERIALS AND METHODS
Plasmids. Site-specific mutation of the S, X, and distal Y/CCAAT elements
has been described (6). Site-specific mutation of the GC box and proximal Y/
CCAAT element were described previously (58). The Ii 395-CAT constructs
were prepared by digestion of the Ii 790-CAT constructs with SacI. This resulted
in removal of a 400-bp fragment, which allowed for efficient primer extension
into the invariant chain promoter using primers specific for the Bluescript KS
vector.
Cell culture and the production of stable cell lines. U-373 MG is a glioblas-
toma multiform cell line which expresses high levels of MHC class II antigens
upon IFN-g induction. These cells were cultured by using McCoy’s 5A medium
supplemented with 8% fetal bovine serum and 2 mM glutamine. To generate cell
lines with integrated promoters, 3 3 106 cells were transfected with 20 mg of each
supercoiled Ii 395-CAT plasmid by electroporation (200 mV, 960 mF, 300 ml of
complete medium; Bio-Rad Gene Pulser). To provide resistance for drug selec-
tion, 1 mg of the neomycin resistance vector pSV2neo was cotransfected with
each construct. Two days posttransfection, selection was initiated by addition of
300 U of G418 (Geneticin; Gibco) per ml of medium. After 12 to 14 days,
well-separated colonies were isolated by using cloning cylinders and amplified.
Monoclonal lines were maintained in the presence of G418, and the drug was
removed only prior to experimental assays. Genomic DNA was isolated from
monoclonal lines, and clones were screened by PCR analysis using the Bluescript
vector-specific primer KSVEC and the chloramphenicol acetyltransferase
(CAT)-specific primer pCAT1.
The 2fTGH and G1B lines have been described (38). These cells were cultured
in Dulbecco’s modified Eagle medium supplemented with 8% fetal bovine serum
and 2 mM glutamine.
In vivo genomic footprinting. Dimethyl sulfate (DMS) treatment of cells and
genomic-DNA preparation were performed as described elsewhere (43).
Cleaved genomic DNA was amplified by using the ligation-mediated PCR
(LMPCR) protocol (40) with modifications (59). Cells (107) were treated for 24 h
with 500 U of recombinant IFN-g (Genentech) per ml before DMS treatment
and genomic DNA isolation. The CAT-specific primer set used to visualize
contacts for the upper strand of the proximal promoter is as follows: pCAT1,
CAACGGTGGTATATCCAGTG (melting temperature [Tm] 5 60°C); pCAT2,
GCTTCCTTAGCTCCTGAAAATCTCGC (Tm 5 63°C); pCAT3, CTTCCTTA
GCTCCTGAAAATCTCGCCAAGC (Tm 5 65°C). For protein-DNA contacts
on the upper strand in the distal promoter domain, the CAT-specific primer
pCAT1 was used along with the invariant-chain-specific primers IiUDP2, ACT
TGGTAGATGTGGAAGTGAAAGC (Tm 5 60°C), and IiUDP3, TTGGTAG
ATGTGGAAGTGAAAGCTACAAAGGC (Tm 5 64°C). Protected regions on
the lower strand in the distal promoter domain were detected with the Blue-
script-specific primer KSVEC, CTATAGGGCGAATTGGAG (Tm 5 58°C) and
the invariant-chain-specific primers IiLDP2, CAAAGTGCTTTCCTGTCTAG
GGAGTGGAC (Tm 5 66°C), and IiLDP3, GTGCTTTCCTGTCTAGGGAG
TGGACATTTGC (Tm 5 67°C). Footprinting of the endogenous invariant chain
promoter for U373-MG, 2fTGH, and G1B was performed with previously de-
scribed primer sets (7). Radiolabelled LMPCR products were separated by using
6% denaturing polyacrylamide gels.
CAT assays. Individual monoclonal cell lines were removed from selectable
media prior to analysis. Cells were either untreated or cultured in the presence
of 500 U of IFN-g per ml. Forty hours after treatment, cells were harvested with
trypsin and washed with phosphate-buffered saline. The cell pellets were resus-
pended in 100 mM Tris, pH 7.8, and lysed by freezing and thawing. Extracts were
heat inactivated at 60°C for 10 min. Reaction mixtures were incubated at 37°C
for 5 h. CAT activity was first analyzed by a xylene extraction-based scintillation
technique (10, 41) using 75 mM unlabelled acetyl coenzyme A in conjunction
with 25 mM [3H]acetyl coenzyme A (NEN). Greater sensitivity was achieved by
using [14C]chloramphenicol, and these results are shown. Acetylated chloram-
phenicol was resolved by thin-layer chromatography and analyzed with a Molec-
ular Dynamics PhosphorImager.
RESULTS
The invariant chain promoter shares the S/X/Y motif found
in all MHC class II promoters; however, the 39 boundary of
these sequences is located 134 bp further upstream of the start
site. At least six additional elements have been described
within the intervening 200 bp of the invariant chain promoter.
These include two NF-kB/Rel sites (7, 17, 42), a putative in-
terferon consensus sequence binding protein site (3), a GC box
and an imperfect Y/CCAAT element (58), and a putative
TATA box. In this report, the imperfect Y/CCAAT element at
250 will be referred to as the proximal Y/CCAAT element
while the Y/CCAAT element centered at position 2200 as part
of the S/X/Y motif will be referred to as the distal Y/CCAAT
element. Full expression of invariant chain requires the GC
box (270) and the proximal Y/CCAAT element (250). These
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sites function synergistically, and they interact with the tran-
scription factors Sp1 and NF-Y, respectively (58).
Generation of stable transfectants for in vivo genomic foot-
printing analysis. In order to assess the roles of individual
cis-acting elements in assembly of the IFN-g-induced invariant
chain promoter, monoclonal cell lines were generated that had
stable integration of wild-type and mutant invariant chain pro-
moters fused to a CAT reporter gene. Each of the Ii 395-CAT
constructs (Fig. 1) was individually transfected into the U-373
MG cell line with a selectable marker, and clonal lines were
isolated from each transfection. Ninety-five individual lines
were created. Genomic DNA was isolated from each line and
screened for plasmid integration by PCR analysis using vector-
and CAT-specific primers flanking the promoter. Thirty-five
lines exhibited productive integration. These lines were subse-
quently screened by DMS genomic footprinting, and seven
lines were eliminated based on high-copy-number integration.
High-copy-number lines were eliminated to prevent titration of
transcription factors which may alter the integrity of genomic
footprinting (55, 60). For each transfected construct, multiple
clones were isolated to ensure that reproducible results would
be obtained in the subsequent genomic footprinting analysis.
The following numbers of clones were examined by in vivo
footprinting: five clones harboring the wild-type construct,
three with the mutated proximal Y/CCAAT construct, five
with the mutated GC construct, two with the mutated distal
Y/CCAAT construct, three with the mutated X construct, and
three with the mutated S construct. All the in vivo footprints
were performed at least twice. Although the level of reporter
CAT expression varied significantly among clones, it is note-
worthy that the in vivo footprints were remarkably similar
when different clones harboring the same construct were ana-
lyzed. Thus, the site of integration did not appear to signifi-
cantly alter the invariant chain footprint patterns.
In vivo functional activity of invariant chain promoter/re-
porter constructs. Transient transfection analysis of the invari-
ant chain promoter previously determined that the distal S, X,
and Y/CCAAT elements are required for IFN-g induction in
the U-373 MG cell line (8) and that additional Sp1 and NF-Y
binding sites are crucial for promoter function in B-lympho-
blastoid cell lines (58). In order to determine the relative
functional contributions of each of these elements for IFN-g
induction of integrated invariant chain promoter activity, indi-
vidual clonal lines were assayed for CAT activity with and
without IFN-g treatment (Fig. 1). Integrated wild-type pro-
moters were inducible by IFN-g, with the levels of induction
for individual clonal lines being 6.9-, 2.9-, 1.3-, and 4.0-fold.
As expected, mutation within each of the distal S, X, and
Y/CCAAT elements results in disruption of IFN-g inducibility
and minimal promoter activity. Mutation of the proximal
Y/CCAAT element also greatly reduces IFN-g inducibility and
promoter activity, while integrated promoters with a mutation
in the GC box consistently retain partial inducibility, with val-
ues ranging from 1.8- to 2.5-fold.
Integrated wild-type and endogenous invariant chain pro-
moters exhibit indistinguishable patterns of in vivo protein-
DNA contacts. Prior to assessing the role of individual cis-
acting elements in establishing promoter occupancy, it was
necessary to determine if the integrated wild-type Ii 395-CAT
construct displayed in vivo protein-DNA contacts similar to
those of the endogenous invariant chain promoter. Primer sets
were directed either to the genomic sequences flanking the
endogenous invariant chain promoter or to the CAT and vec-
tor sequences flanking the integrated invariant chain promoter
(Fig. 2A). The focus of this analysis was detection of protein-
DNA contacts at 24 h post-treatment with IFN-g. At this time,
invariant chain transcription is maximal (7), and protein-DNA
contacts are maximal over the entire promoter (8, 58). Figure
2B compares in vivo protein-DNA contacts for both the en-
dogenous invariant chain promoter and the integrated wild-
type promoter. The multiple guanine protections and enhance-
ments in the GC box and the single protected guanine in the
proximal Y/CCAAT element were indistinguishable for the
two promoters (for sequence, see Fig. 3A). Similar results were
obtained for the upper and lower strands in the distal promoter
region (data not shown). The results of this analysis confirm
the validity of using integrated invariant chain promoters to
study promoter assembly and provide a system to test the
effects of mutation on this process.
cis mutations that affect transcription factor occupancy of
proximal promoter elements. Previous results had demon-
strated that the invariant chain proximal promoter Y/CCAAT
element and GC box are synergistic in function. Synergism
between these factors can be explained in part by cooperative
binding of Sp1 and NF-Y to these sites in vitro. Sp1 binding
adjacent to this imperfect Y/CCAAT element prolongs NF-Y’s
off-rate 4.5-fold, and NF-Y stabilizes Sp1 binding to a similar
extent (58). To determine if this cooperativity is also found in
FIG. 1. Functional requirement of individual cis-acting elements for IFN-g-induced transcription of stably integrated invariant chain promoter activity. A schematic
of the Ii 395 promoter constructs used in this report is shown on the left. Site-specific disruption of individual elements is indicated (3). CAT activity is reported as
the mean for three independent clones from each type of cell line (four for the wild type [WT] and the GC mutant [mut GC]) with standard error of the mean. The
mean fold induction is provided to the right of each set of bars. dist., distal; prox., proximal.
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vivo, stably integrated invariant chain promoters bearing mu-
tations in either the proximal Y/CCAAT element or the GC
box were analyzed by genomic footprinting. Protein-DNA con-
tacts were analyzed only for the upper strand since the lower
strand has relatively few protected regions in vivo (58). Muta-
tion of the proximal Y/CCAAT element substantially disrupts
Sp1 binding to the GC box, as the multiple strong guanine
protections and enhancements are no longer detected (Fig. 3B,
lanes 3 and 4). Mutation of the GC box results in a loss of
protection within the GC box as expected, and the protection
of the single guanine in the Y/CCAAT element was reduced
but not eliminated (Fig. 3B, lanes 5 and 6). These results show
that Sp1 binding in vivo is dependent on NF-Y binding at the
adjacent Y/CCAAT element and that NF-Y binding is en-
hanced by Sp1 binding but is not dependent on it.
The distal Y/CCAAT element and X box were analyzed for
their roles in establishing transcription factor occupancy in the
proximal promoter domain. Although the distal Y/CCAAT ele-
ment is 154 bp away from the proximal Y/CCAAT element,
mutation of this site completely eliminates any detectable pro-
tection of the proximal Y/CCAAT element and GC box (Fig.
3B, lanes 7 and 8). When the X box is mutated, however,
partially protected regions in both the proximal Y/CCAAT
element and the GC box are consistently observed (Fig. 3B,
lanes 9 and 10). These results show that DNA-binding events
in the distal promoter domain are critical for transcription
factor occupancy within the proximal promoter domain, with
NF-Y binding to the distal Y/CCAAT element being abso-
lutely required for this event.
cis mutations that affect transcription factor occupancy of
distal promoter elements. Transcription factor contacts within
the proximal promoter domain were affected by all of the
mutations tested above, albeit to different degrees. A similar
analysis was undertaken to assess the role of individual cis-
acting elements in establishing transcription factor occupancy
of the distal promoter domain. It was of interest to determine
to what extent could proximal promoter mutations influence in
vivo binding within the distal promoter domain. Mutation of
the proximal Y/CCAAT element results in partially reduced
protein-DNA contacts in the distal Y/CCAAT element and X
box. On the lower strand the two protected guanines in the
distal Y/CCAAT element and three protected guanines in the
X box are consistently and partially reduced but not eliminated
(Fig. 4B, lanes 3 and 4). Although the distal Y/CCAAT ele-
ment shows no protected regions on the upper strand, contacts
are detected within the X box (Fig. 4C, lanes 3 and 4). In
contrast, when the GC box is mutated, the lower-strand gua-
nine protections within the distal Y/CCAAT element and X
FIG. 2. In vivo footprinting of a stably integrated wild-type invariant chain promoter shows protein-DNA contacts identical to those of the endogenous promoter.
(A) Schematic representation of an integrated invariant chain promoter. Arrows indicate the relative positions of primers used for in vivo footprinting. Filled arrows
represent primers specific for the integrated plasmid vector and CAT sequences. Open arrows indicate primers specific for the human invariant chain promoter. p1,
p2, and p3, primers 1, 2, and 3 of the LMPCR protocol. (B) In vivo genomic footprints of the upper strand in the proximal promoter domain. Lanes In Vitro,
deproteinized genomic DNA methylated in vitro to reveal the complete guanine ladder. In vivo ladders were generated by using genomic DNA isolated from cells
treated with DMS in culture. Lanes 1 and 2, amplification of the endogenous invariant chain promoter; lanes 3 and 4, amplification of the integrated wild-type invariant
chain promoter. Open arrows, protected regions; filled arrows, enhancements. Partially protected regions or enhancements are indicated by shorter arrows. Results are
reproducible for five wild-type cell lines.
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box are not significantly reduced (Fig. 4B, lanes 5 and 6).
Likewise, the guanine enhancement at the 59 boundary of the
X box and four protected guanines within the X box are un-
changed (Fig. 4C, lanes 5 and 6). These results show that while
the proximal Y/CCAAT element can influence transcription
factor binding in the distal promoter domain, the GC box has
little to no long-distance effect on promoter occupancy.
The distal Y/CCAAT element and X box were next analyzed
to determine their role in establishing transcription factor oc-
cupancy of the distal promoter domain. Mutation of the distal
Y/CCAAT element completely disrupted adjacent X box bind-
ing. The three strongly protected guanines on the lower strand
of the X box are lost (Fig. 4B, lanes 7 and 8). This result was
confirmed by analysis of the upper strand where the guanine
enhancement at the 59 boundary of the X box and four pro-
tected guanines within the X box are no longer detected (Fig.
4C, lanes 7 and 8). Also, mutation of the X box results in a loss
of detectable guanine protection in the distal Y/CCAAT ele-
ment (Fig. 4B, lanes 9 and 10). These results provide strong
evidence that in vivo transcription factor loading at the distal
Y/CCAAT element and at the X box is codependent.
Mutation of the S element does not affect transcription
factor occupancy. Although the S element is required for
IFN-g induction, in vivo protein-DNA contacts are not de-
tected within the S element for both DRA and invariant chain
(8, 59). The role of the S element in assembly of the active
invariant chain promoter was studied by in vivo footprinting of
integrated invariant chain promoters with a mutated S ele-
ment. Protein-DNA contacts in both the proximal promoter
(Fig. 5, lanes 1 and 2) and the distal promoter (Fig. 5, lanes 3
and 4) are identical to those obtained for the wild-type pro-
moter, indicating that an intact S element is not necessary for
promoter occupancy even though this element is absolutely
required for IFN-g induction and promoter function.
Physiologic validation of the X-box mutation results ob-
tained with the RFX-deficient cell line G1B. One approach to
verify the validity of the experiments described above is to
compare results obtained by using the transfected mutant con-
structs with mutant cell lines harboring defects in the protein
factors which bind to these sites. The G1B cell line lacks IFN-g
induction of MHC class II genes as well as the invariant chain
FIG. 3. In vivo genomic footprinting of stably integrated mutant invariant
chain promoters reveals the requirement for NF-Y binding in establishing tran-
scription factor occupancy in the proximal promoter domain. (A) Proximal
promoter sequence and summary of in vivo protein-DNA interactions revealed
by DMS footprinting. cis-acting elements are boxed. Open arrows, protected
regions; filled arrows, enhancements. (B) In vivo footprints on the upper strand
in the proximal promoter domain. The cell line is indicated above each pair of
lanes. Contacts indicated for each type of integrated promoter were consistent
for at least two independent cell lines. Visible sequence alterations resulting
from mutations (mut) are indicated. WT, wild type. All other symbols are as
described for Fig. 2B.
FIG. 4. In vivo genomic footprinting of stably integrated mutant invariant
chain promoters reveals significant disruption of protein-DNA contacts in the
distal promoter domain upon mutation of distal elements but not proximal
elements. (A) Distal promoter sequence and summary of in vivo protein-DNA
interactions revealed by DMS footprinting. The S, X, and Y/CCAAT elements
are boxed. All other symbols are as in Fig. 3A. (B) In vivo genomic footprints for
the lower strand. (C) In vivo genomic footprints on the upper strand.
FIG. 5. In vivo genomic footprinting of stably integrated invariant chain
promoters with site-specific mutation of the S element shows full transcription
factor occupancy in both the proximal and the distal promoter domains. Foot-
prints of the upper strand of the proximal promoter are shown in lanes 1 and 2.
Footprints of the lower strand of the distal promoter are shown in lanes 3 and 4.
Specific alterations in the S element can be visualized in the lower strand (mut).
Individual contacts were reproducible for three independent cell lines.
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(38). Nuclear extracts from G1B lack RFX binding activity
(12), and more recent analysis has revealed that the RFX5
component of RFX is mutated in this cell line (5a). In vivo
footprinting of the endogenous invariant chain promoter was
performed by using the wild-type control, 2fTGH. In vivo foot-
prints are detected over the X box and distal Y/CCAAT ele-
ment (Fig. 6, lanes 1 and 2) and the GC box and proximal Y/
CCAAT element (Fig. 6, lanes 5 and 6). The 2fTGH footprints
are reproducibly weaker than those of the U-373 MG cell line
used in all of the previous figures. A similar analysis using G1B
shows a lack of footprints at both distal X and Y/CCAAT
elements (Fig. 6 lanes 3 and 4); however, the proximal GC
element is still partially occupied (Fig. 6, lanes 7 and 8). Thus,
the invariant chain promoter is similarly disrupted both in cells
defective in the X-box binding factor and in the transfected
X-box mutation cell lines. This demonstrates that the integrat-
ed promoter analysis used in this report is physiologically valid.
DISCUSSION
In this study, we have analyzed the invariant chain promoter
to determine the role of individual cis-acting elements in as-
sembly of a complex nucleoprotein structure. This in vivo ap-
proach has defined a hierarchy of protein-DNA interactions
over 250 bp of a promoter in which some mutations have
localized effects on transcription factor binding, others have an
impact over the entire promoter, and some have little to no
effect. Our results show that the Y/CCAAT-binding factor
NF-Y is absolutely required for transcription factor binding to
adjacent sites as well as to sequences as far as 150 bp away.
Whereas functional analysis of the invariant chain promoter
has shown that the distal S, X, and Y/CCAAT elements are
equally critical for IFN-g-induced expression, analysis of pro-
moter occupancy by DMS footprinting has revealed that these
elements do not equally contribute to establishing promoter
occupancy. Mutation of the distal Y/CCAAT element in this
motif entirely eliminates detectable protein-DNA contacts not
only at the adjacent X box, but also at the Sp1 and NF-Y
binding sites in the proximal promoter domain located 150 bp
away. These results show that NF-Y binding to the distal
Y/CCAAT element has a global role in factor association for
the entire promoter. Mutation of the X box results in a signif-
icant disruption of protein-DNA contacts within the distal pro-
moter domain, but only partial reduction of transcription fac-
tor binding in the proximal promoter domain is observed. This
partial disruption could be explained by the fact that X-box
mutation disrupts NF-Y binding to the distal Y/CCAAT ele-
ment, thereby impairing the stabilizing effect that this element
has on the proximal promoter domain. Finally, mutation of the
S element resulted in no disruption of transcription factor
binding to the invariant chain promoter. Despite the absence
of an effect on promoter occupancy, IFN-g induction and pro-
moter activity are greatly reduced upon mutation of the S
element. This indicates that an occupied promoter is not suf-
ficient for transcriptional activation, and additional steps re-
quiring a functional S element are necessary for promoter
activity.
The codependency of promoter occupancy at the distal
Y/CCAAT element and X box is in agreement with biochem-
ical evidence which reveals physical interaction and cooperat-
ivity between the factors binding at X and Y (45, 60). It is
noteworthy that others have observed that the invariant chain
is expressed in B-lymphoblastoid cell lines which lack RFX (15,
29), although it is unclear to what level. In contrast, when an
RFX-deficient, IFN-g-responsive cell line was examined, in-
variant chain expression was abolished (38). Similarly, another
set of mutants selected for the lack of IFN-g-induced class II
MHC expression are also defective for invariant chain induc-
tion (11). Differences between constitutive class II MHC ex-
pression and that induced by IFN-g are observed with regard
to the role of the master regulator, CIITA. It is widely accepted
that CIITA does not influence promoter loading of the class II
MHC genes. This is now found to apply only to B-cell lines,
while CIITA is required for promoter loading in IFN-g-induc-
ible cell lines (57a). These experiments together lead us to
conclude that there are fundamental differences between the
mechanisms governing constitutive class II MHC and invariant
chain gene expression and that induced by IFN-g. One postu-
lation is that constitutive expression of the invariant chain in B
lymphocytes may serve an additional function in addition to
antigen presentation. Indeed, recent evidence suggests that the
invariant chain, but not MHC class II, is critical for late stages
of B-cell development (47).
Another difference between our work with IFN-g-inducible
cells and the work of others with B-cell lines is that different
results were obtained by using a similar strategy of footprinting
transfected mutated promoters. We have consistently observed
that the mutation of specific elements can influence the occu-
pancy of other elements within the DRA promoter, and now
with the invariant chain promoter. In vivo footprinting analysis
of transfected DRA promoters in a B-lymphoblastoid line has
shown that mutation of either the X or the Y/CCAAT element
does not affect binding at other sites (31). This finding is
unexpected because in bare lymphocyte syndrome cell lines,
the lack of functional RFX is known to result in an unoccupied
promoter (30, 32). The authors suggest that this may be due to
differences between the integration locus and that of the MHC.
In our studies using IFN-g-inducible cells, mutation of X and
Y/CCAAT elements has effects on the occupancy of other
elements, and this is observed apparently regardless of inte-
gration site. Importantly, the result obtained with the trans-
fected X-box mutation constructs is further confirmed with a
mutant cell line lacking RFX. Thus, in the G1B cell line, the in
vivo footprint of the invariant chain promoter is similar to that
of the transfected promoter which bears a mutated X element.
Mutations of the proximal Y/CCAAT element and GC box
reveal distinct effects on promoter occupancy. Mutation of the
GC box only weakly disrupts binding to the proximal
Y/CCAAT element, and little disruption of transcription factor
FIG. 6. The RFX-deficient cell line G1B displays a partially unloaded pro-
moter upon IFN-g induction. In vivo footprints are shown for both the distal
(dist.) (lanes 1 to 4) and the proximal (prox.) (lanes 5 to 8) promoter regions of
the endogenous invariant chain promoter. The parental cell line 2fTGH is
included (lanes 1, 2, 5, and 6) to show contacts in a cell line where invariant chain
transcription is induced normally. The results were repeated with two different
DNA preparations for each cell line. The normal protected regions and enhance-
ments are indicated (arrows).
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binding in the distal promoter domain is observed. These re-
sults are reflected in the partial IFN-g inducibility that is re-
tained by integrated GC mutation promoters. The proximal
Y/CCAAT element, however, plays a significant role in estab-
lishing promoter occupancy, having both a local effect in that it
is required for Sp1 binding to the neighboring GC box as well
as a stabilizing effect for factors binding to the distal Y/
CCAAT element and X box. The in vivo codependency of
binding to the proximal Y/CCAAT element and GC box agrees
with their in vitro cooperative binding shown previously (58).
Why does NF-Y binding play such a critical role in helping
other transcription factors to bind, and how can it mediate this
effect over 150 bp? The answer may lie in the unique structure
of NF-Y. DNA binding is mediated by the evolutionarily con-
served domains in each of the three subunits (Fig. 7A). The
conserved sequences of NF-YB and NF-YC show sequence
similarity with the histone fold motifs of the histone proteins
H2B and H2A, respectively (4, 48). This structural motif has
emerged as the fundamental architectural domain of the nu-
cleosome (1, 2). A number of proteins share this motif, includ-
ing several TFIID-associated factors (4). Indeed, dTAFII42
and dTAFII62 have been shown to adopt the histone fold and
form tetrameric structures resembling the nucleosome core
(61). Since the nucleosome octamer is assembled via the rever-
sible association of H2A/H2B dimers with a central (H3H4)2
core tetramer (22), the histone fold motifs of NF-YB and
NF-YC may allow for interactions with the core tetramer (49).
We suggest a speculative model for the invariant chain pro-
moter (Fig. 7B) wherein sequence-specific binding mediated
by the NF-YA subunit (62) could result in the formation of a
Y/CCAAT element-positioned nucleosome-like structure al-
lowing for efficient transcription complex formation. It is in-
teresting to note that simultaneous mutation of two Y/CCAAT
elements in the Xenopus hsp70 promoter results in disruption
of chromatin, yielding an altered pattern of micrococcal nucle-
ase cleavage (33).
In conclusion, the analysis of mutant promoter constructs by
in vivo genomic footprinting represents a powerful and high-
resolution approach for dissecting the contributions of individ-
ual cis-acting elements in establishing promoter occupancy.
This approach has revealed that Y/CCAAT element binding by
NF-Y is a required event for assembly of a complex promoter.
This requirement is influenced by the context of the promoter.
The X element also has far-reaching effects on promoter load-
ing although less than that of the Y element.
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